BI opens second branch of digital lab in China

Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in July this year in China.

The many faces of patient-pharma co-creation

Ahead of her appearance at eyeforpharma Barcelona, Merck’s director of patient advocacy and strategic partnerships, Vanessa Pott, tells us how the company is approaching patient centric

Merck, Pfizer’s Bavencio flunks head and neck cancer trial

Merck partners with tech firm AMCM on tablet 3D printing

BMS builds case for long-term use of Opdivo in kidney cancer

Bristol-Myers Squibb has unveiled long-term results from its immunotherapy Opdivo in the most common form of kidney cancer, showing that more than a quarter of patients were alive after fiv

FDA to quickly review Novartis' capmatinib in rare lung canc...

The FDA has agreed to fast-track its regulatory review of Novartis’ capmatinib in a hard-to-treat form of lung cancer.